-
TIME
AI Writes Scientific Papers That Sound Great—but Aren’t Accurate
ChatGPT is luring scientists, who are under pressure to publish papers in reputable scientific journals.
-
Mirror Indy
Pregnant women in Indiana are being exposed to toxic herbicides, study shows
Pregnant women in Indiana are being exposed to toxic herbicides at high rates relative to other states, according to a new study from IU School of Medicine.
-
WFYI
A new blood test would objectively determine psychosis risk and best treatments
Researchers from Indiana University School of Medicine have developed a blood test for people with schizophrenia and related psychotic disorders.
-
The Guardian
Pregnant women in Indiana show fourfold increase in toxic weedkiller in urine – study
Seventy percent of pregnant women in state had herbicide dicamba in their urine, up from 28% in an earlier study.
-
MSN
IU researchers develop a breakthrough new blood test for schizophrenia
A team of researchers led by Indiana University School of Medicine faculty have developed a breakthrough new blood test for schizophrenia, a psychiatric disorder that includes hallucinations and delusions.
-
ScienMag
Cancer researcher Craig B. Thompson named 2024 Watanabe Prize winner
Pioneering cancer researcher Craig B. Thompson, MD, has been named the 2024 winner of the August M. Watanabe Prize in Translational Research.
-
Health Day
Blood Test to Predict Schizophrenia Shows Promise
More than 3 million people in the United States have schizophrenia, a disorder marked by hallucinations and delusions, or a related psychotic illness.
-
New York Post
Breakthrough blood test predicts schizophrenia risk, best treatments
Scientists say they have developed a breakthrough new blood test for schizophrenia — a chronic brain disorder that often causes delusions, hallucinations and disorganized speech.
-
Science
Alzheimer’s disease may have been transmitted in now-banned hormone treatments
Other researchers stress that no one need fear “catching” the disease
-
Indiana Public Media
IU School of Medicine receives $3 million grant to study sickle cell treatment
The study will test the effectiveness of Propranolol, a beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety.
-
Healio
Dry January campaign aims to make ‘first step’ toward abstinence less daunting
Each January, Alcohol Change UK runs Dry January, a post-holiday campaign that encourages people to abstain from alcohol for 31 days.
-
Sickle Cell Anemia News
$3M awarded to study repurposing of blood pressure drug for SCD
US study to assess propranolol in preclinical models of SCD-linked heart disease